Too Much Hype Doomed Once-Successful Wyeth CEO

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

In 2007, Bob Essner felt justifiably triumphant. He had engineered a successful turnaround of Wyeth, the pharmaceutical giant, after six years of reinventing the company. But even after in­­creas­­ing revenue by 30%—to $20.4 billion—Essner suddenly lost his job. What went wrong?

Hey, check out all the research scientist jobs. Post your resume today!

Back to news